ES8403718A2 - Procedimiento de criodesecacion de sustancias cosmeticas y de diagnostico en solucion o suspension en disolventes. - Google Patents

Procedimiento de criodesecacion de sustancias cosmeticas y de diagnostico en solucion o suspension en disolventes.

Info

Publication number
ES8403718A2
ES8403718A2 ES521401A ES521401A ES8403718A2 ES 8403718 A2 ES8403718 A2 ES 8403718A2 ES 521401 A ES521401 A ES 521401A ES 521401 A ES521401 A ES 521401A ES 8403718 A2 ES8403718 A2 ES 8403718A2
Authority
ES
Spain
Prior art keywords
cosmetic
pharmaceutical
dietetical
diagnostic uses
preparing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES521401A
Other languages
English (en)
Other versions
ES521401A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cephalon France SAS
Original Assignee
Laboratoire L Lafon SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoire L Lafon SA filed Critical Laboratoire L Lafon SA
Publication of ES8403718A2 publication Critical patent/ES8403718A2/es
Publication of ES521401A0 publication Critical patent/ES521401A0/es
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/11—Encapsulated compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/31—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)

Abstract

PROCEDIMIENTO PARA LA CRIODESECACION DE SUSTANCIAS COSMETICAS Y DE DIAGNOSTICO EN SUSPENSION, EN DISOLVENTES (CERTIFICADO DE ADICION DE LA PATENTE NUM. 473.459).CONSISTE EN PULVERIZAR EN FORMA DE GOTICULAS UNA MEZCLA QUE CONTIENE AL MENOS UN INGREDIENTE ACTIVO Y AL MENOS UNA SUSTANCIA FILMOGENA, A UNA TEMPERATURA ENTRE 50JC Y 150JC; SECAR LAS GOTICULAS MEDIANTE UNA CORRIENTE GASEOSA A UNA TEMPERATURA ENTRE 100JC Y 150JC INTRODUCIDA EN CO-CORRIENTE O EN CONTRACORRIENTE CON LAS GOTICULAS; Y RECOGER LAS PARTICULAS Y SOMETERLAS A LIOFILIZACION.TIENE APLICACIONES PARALA PREPARACION DE FORMAS GALENICAS QUE SE EMPLEAN EN TERAPEUTICA, DIETETICA, COSMETICA Y DIAGNOSTICO.
ES521401A 1983-01-25 1983-04-12 Procedimiento de criodesecacion de sustancias cosmeticas y de diagnostico en solucion o suspension en disolventes. Granted ES521401A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8301115A FR2539626B2 (fr) 1983-01-25 1983-01-25 Nouveau procede de preparation de formes galeniques utiles notamment en therapeutique, dietetique, cosmetique et diagnostic, et formes obtenues selon ce procede

Publications (2)

Publication Number Publication Date
ES8403718A2 true ES8403718A2 (es) 1984-04-01
ES521401A0 ES521401A0 (es) 1984-04-01

Family

ID=9285262

Family Applications (1)

Application Number Title Priority Date Filing Date
ES521401A Granted ES521401A0 (es) 1983-01-25 1983-04-12 Procedimiento de criodesecacion de sustancias cosmeticas y de diagnostico en solucion o suspension en disolventes.

Country Status (11)

Country Link
US (1) US4490407A (es)
AU (1) AU560897B2 (es)
BE (1) BE898749A (es)
CA (1) CA1187795A (es)
CH (1) CH654207A5 (es)
ES (1) ES521401A0 (es)
FR (1) FR2539626B2 (es)
GB (1) GB2133983B (es)
IT (1) IT1174474B (es)
PT (1) PT78006B (es)
ZA (1) ZA84565B (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2561916B1 (fr) * 1984-03-30 1987-12-11 Lafon Labor Forme galenique pour administration orale et son procede de preparation par lyophilisation d'une emission huile dans eau
IL86892A (en) * 1987-07-08 1993-04-04 Lafon Labor Filter comprising a material obtained by freeze-drying, its preparation and its use, especially in pharmacy
IT1231260B (it) * 1988-11-16 1991-11-28 Sergio Bertini Curri Farmaco e metodo per aumentare volume e velocita' del flusso microcircolatorio capillare a livello cutaneo
MY106919A (en) * 1990-08-31 1995-08-30 Kao Corp Composition for use in oral cavity.
FR2698560B1 (fr) * 1992-11-30 1995-02-03 Virbac Laboratoires Principes actifs pulvérulents stabilisés, compositions les contenant, leur procédé d'obtention et leurs applications.
US5981719A (en) * 1993-03-09 1999-11-09 Epic Therapeutics, Inc. Macromolecular microparticles and methods of production and use
US6090925A (en) * 1993-03-09 2000-07-18 Epic Therapeutics, Inc. Macromolecular microparticles and methods of production and use
US5843347A (en) * 1993-03-23 1998-12-01 Laboratoire L. Lafon Extrusion and freeze-drying method for preparing particles containing an active ingredient
FR2702968B1 (fr) * 1993-03-23 1995-06-23 Lafon Labor Procédé de préparation de particules renfermant un ingrédient actif par extrusion et lyophilisation .
FR2703588B1 (fr) * 1993-04-05 1995-06-23 Oreal Composition granulee a base de derives peroxydes utilisable pour la decoloration des cheveux et procede de preparation de ladite composition.
DE4317172A1 (de) * 1993-05-22 1995-01-05 Rhone Poulenc Rorer Gmbh Geschmacksneutrale und schnellfreisetzende Buflomedil-Hydrochlorid-Arzneiform und Herstellungsverfahren desselben
FR2740357B1 (fr) * 1995-10-25 1997-11-28 Rhone Poulenc Chimie Granules redispersables dans l'eau comprenant une matiere active sous forme liquide et un tensio-actif non ionique du type alcoxyles
US5686133A (en) * 1996-01-31 1997-11-11 Port Systems, L.L.C. Water soluble pharmaceutical coating and method for producing coated pharmaceuticals
DE60128910T2 (de) 2000-04-27 2008-02-28 Verion Inc. Nullte-ordnung-freisetzung und temperatur-kontrollierte mikrokapseln sowie herstellungsverfahren
US6541030B2 (en) 2000-09-27 2003-04-01 Verion Inc. Instant water dissolvable encapsulate and process
US7491263B2 (en) 2004-04-05 2009-02-17 Technology Innovation, Llc Storage assembly
US8012457B2 (en) 2004-06-04 2011-09-06 Acusphere, Inc. Ultrasound contrast agent dosage formulation
US20080031947A1 (en) * 2006-07-24 2008-02-07 Cima Labs Inc. Orally dissolvable/disintegrable lyophilized dosage forms containing protected
EP2359812A1 (en) 2010-01-18 2011-08-24 Cephalon France Oral lyophilised compositions
WO2011086194A1 (en) 2010-01-18 2011-07-21 Cephalon France Improved oral lysophilisates containing pvp/va
DE102010022174A1 (de) * 2010-05-12 2011-11-17 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Neue Darreichungsformen für Cineol

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1289430A (fr) * 1960-04-04 1962-04-06 Perfectionnement aux techniques d'enrobage de principes médicamenteux et produits ainsi obtenus
GB1227744A (es) * 1967-07-04 1971-04-07
DE2017373A1 (de) * 1969-04-15 1971-04-22 Orsymonde S A , Paris Lyophihsierte Produkte und Ver fahren zu ihrer Herstellung
CH558659A (fr) * 1969-11-26 1975-02-14 Orsymonde Procede pour la preparation d'une composition lyophilisee a usage hygienique.
US3721725A (en) * 1970-08-14 1973-03-20 Du Pont Process for preparing powder blends
BE786307A (fr) * 1971-07-16 1973-01-15 Ciba Geigy Procede d'encapsulation de substances finement dispersees dans un liquide selon le procede de condensation par atomisation
GB1482785A (en) * 1974-10-30 1977-08-17 Du Pont Method of preparing a homogeneous lyophilised composition
FR2403078A1 (fr) * 1977-09-19 1979-04-13 Lafon Labor Nouveau procede de preparation de formes pharmaceutiques, cosmetiques ou de diagnostic
JPS5598120A (en) * 1979-01-16 1980-07-25 Shin Etsu Chem Co Ltd Preparation of drug having enteric coating

Also Published As

Publication number Publication date
GB2133983B (en) 1986-11-05
FR2539626A2 (fr) 1984-07-27
AU560897B2 (en) 1987-04-16
CA1187795A (en) 1985-05-28
ZA84565B (en) 1984-09-26
ES521401A0 (es) 1984-04-01
GB2133983A (en) 1984-08-08
IT1174474B (it) 1987-07-01
CH654207A5 (fr) 1986-02-14
PT78006A (en) 1984-02-01
PT78006B (en) 1986-03-27
BE898749A (fr) 1984-05-16
IT8419308A0 (it) 1984-01-25
US4490407A (en) 1984-12-25
GB8315086D0 (en) 1983-07-06
FR2539626B2 (fr) 1985-06-21
AU2378984A (en) 1984-07-26

Similar Documents

Publication Publication Date Title
ES8403718A2 (es) Procedimiento de criodesecacion de sustancias cosmeticas y de diagnostico en solucion o suspension en disolventes.
PT74703A (en) Process for the preparation of pharmaceutical compositions for topical use which are penetrable through the skin and contain as an active ingredient amongst others (e)-n-methyl-6,6-dimethyl-n-(naphtylmethyl)-hept-2-en-4-inyl-1-amine
HUT45023A (en) Process for production of derivatives of 1,5-diphenilpirasole-carbonic acid and selective herbicides containing these compositions as antidotum and derivatives of phenoxipropion acid as herbicide active substance
HUT51865A (en) Herbicides containing as active substance derivatives of salycil acid or their sulfhur-analoges, further compositions regulating the growt of plants containing salycil acid derivatives and process for production of the active substances
IE800117L (en) Depot body on the basis of silicone rubber for sustained¹drug release
HUT39971A (en) Pesticide compositions containing 3,5-diaryl-1,2,4-triazole derivatives as active ingredients and process for preparing the active substances
PT86186A (en) Process for the preparation of benzimidazol derivatives and of pharmaceutical compositions containing the same
EP0171528A3 (en) Controlled release pharmaceutical preparations
AU5284186A (en) Liposome aerosol compositions
HUT39569A (en) Pesticide compositions containing 13beta-milbemycin derivatives and process for preparing the active ingredients
IT8019711A0 (it) Composizioni da usarsi come cosmetici e procedimento per lapreparazione dei loro ingredienti attivi.
HUT41750A (en) Process for preparing 2-hydroxy-4h-3,1-benzazin-4-one derivatives, pharmaceutical compositions containing thereof as active ingredients and intermediers thereof
ZA848141B (en) New cyclic benzensulfonamides,process for their preparation and their use as active substance of pharmaceutical compositions
HUT47542A (en) Herbicides and plant growth regulators comprising substituted phenoxy-pyridine derivatives as active ingredient and process for producing the active ingredients
SE8601457D0 (sv) Compositions of liposomes and b?712-receptor active substances for inhalation
HUT46508A (en) Insecticidal compositions comprising 6-member heterocyclic derivatives of n'-substituted-n,n'-diacylhydrazine and process for producing the active ingredients
HUT41229A (en) Pesticide, particularly insecticide compositions and process for preparing benzamides to be applied as active ingredients thereof
HUT49596A (en) Herbicides comprising iminophenylthiazolidine derivatives as actie ingredient and process for producing the active ingredients
HUT47124A (en) Process for producing pharmaceutical compositions comprising organic platinum complex as active ingredient and the active ingredients
HUT44011A (en) Herbicide compositions containing n-substituted-3,4,5,6-tetrahydro-phtalimide derivatives as active components and process for producing the active components
HU901386D0 (en) Antidotes comprising 2,3-substituted 1,8-naphthyridines, antidoted herbicidal compositions, and process for preparation of the active ingredients
HUT41235A (en) Pesticide, particularly insecticide compositions and process for preparing benzoyl-carbamides to be applied as active ingredients thereof
GB2028813B (en) 1-(2,6-dihalobenzoyl)-3-(5-substituted-2-pyridinyl)ureas their preparation formulations and use as insecticides
HU901384D0 (en) Antidotes comprising substituted 1,8-naphthyridines and process for preparations of the active ingredients
DE3166825D1 (en) Process for manufacture of a coated acetylsalicylic-acid formulation

Legal Events

Date Code Title Description
FD2A Announcement of lapse in spain

Effective date: 20170710